Provided by Tiger Trade Technology Pte. Ltd.

PepGen Inc.

3.14
+0.10503.46%
Post-market: 3.140.00000.00%19:30 EDT
Volume:672.16K
Turnover:2.11M
Market Cap:217.02M
PE:-2.64
High:3.23
Open:3.09
Low:3.03
Close:3.04
52wk High:7.80
52wk Low:1.13
Shares:69.12M
Float Shares:36.14M
Volume Ratio:0.91
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1903
EPS(LYR):-2.1234
ROE:-75.45%
ROA:-39.12%
PB:1.82
PE(LYR):-1.48

Loading ...

PepGen Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)

TIPRANKS
·
Aug 06

PepGen Q2 EPS $(0.26) Beats $(0.29) Estimate

Benzinga Earnings
·
Aug 06

PepGen Q2 Net Loss Narrows as Expenses Fall

Reuters
·
Aug 06

PepGen Advances PGN-Edodm1 into 12.5 Mg/kg Cohort in Phase 2 Freedom2-DM1 Trial

Reuters
·
Aug 06

PepGen Q2 FY26 Net Loss Narrows 22.84% to $17.81 Million

Reuters
·
Aug 06

PepGen Q2 EPS USD -0.26

Reuters
·
Aug 06

PepGen - Cash of $117.20 Mln as of June 30, 2026; Funds Operations into Q4 2027

THOMSON REUTERS
·
Aug 06

Press Release: PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Dow Jones
·
Aug 06

PepGen - no Cumulative Toxicity or Treatment Discontinuations Reported at 5 Mg/Kg and 10 Mg/Kg

THOMSON REUTERS
·
Aug 06

PepGen - to Report 10 Mg/Kg Freedom2 Cohort Results in November

THOMSON REUTERS
·
Aug 06

PepGen to Advance Pgn-Edodm1 into Highest Dose Cohort in Phase 2 Freedom2-Dm1 Study Following Dsmb Review

THOMSON REUTERS
·
Aug 06

PepGen Inc Expected to Post a Loss of 29 Cents a Share - Earnings Preview

Reuters
·
Aug 03

PepGen shareholders ratify KPMG as independent auditor for 2026 fiscal year

Reuters
·
Jun 23

Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), CG Oncology, Inc. (CGON)

TIPRANKS
·
Jun 21

PepGen Initiated at Buy by Craig-Hallum

Dow Jones
·
Jun 16

Craig-Hallum Initiates PepGen at Buy With $11 Price Target

MT Newswires Live
·
Jun 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG) and West Pharmaceutical Services (WST)

TIPRANKS
·
May 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

PepGen presents FREEDOM-DM1 trial data for PGN-EDODM1 at IDMC-15

Reuters
·
May 21